HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Víctor González-Ruiz Selected Research

luotonin A

10/2021Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation.
10/2014Challenging core-shell stationary phases with the separation of closely related anti-cancer compounds: performance studies and application to drug quantitation in cell cultures with multi-well plate clean-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Víctor González-Ruiz Research Topics

Disease

3Neoplasms (Cancer)
10/2021 - 01/2014
2Inflammation (Inflammations)
04/2021 - 01/2012
1Neuroblastoma
10/2021
1Carcinoma (Carcinomatosis)
10/2021
1Gliosis
04/2021
1Acute Pain
11/2020
1Confusion (Bewilderment)
11/2020
1Hypesthesia (Numbness)
11/2020
1Neuroinflammatory Diseases
10/2019
1Prion Diseases (Transmissible Spongiform Encephalopathies)
02/2013
1Proteostasis Deficiencies
02/2013
1Fever (Fevers)
01/2012
1Pain (Aches)
01/2012

Drug/Important Bio-Agent (IBA)

2CamptothecinIBA
10/2021 - 10/2014
2luotonin AIBA
10/2021 - 10/2014
2Pharmaceutical PreparationsIBA
11/2020 - 10/2014
1AlkaloidsIBA
10/2021
1CyclodextrinsIBA
10/2021
1Lactic Acid (Lactate)FDA LinkGeneric
04/2021
1Proteins (Proteins, Gene)FDA Link
04/2021
1CytokinesIBA
04/2021
1NF-kappa B (NF-kB)IBA
04/2021
1Opioid Analgesics (Opioids)IBA
11/2020
1Tramadol (K315)FDA LinkGeneric
11/2020
1trimethyltinIBA
10/2019
1Organometallic CompoundsIBA
10/2019
1SolventsIBA
10/2014
1styrylquinolineIBA
02/2013
1Analgesics (Analgesic Drugs)IBA
01/2012
1AntipyreticsIBA
01/2012

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2014
1Therapeutics
02/2013